Thursday, September 24, 2015
Hunter Medical Research Institute
Just received notification today of an offer to commence a PhD in breast cancer genomics at the Hunter Medical Research Institute 👍
Tuesday, December 17, 2013
NEW breast cancer research presentations for the Symphony suite of breast cancer tests (MammaPrint ® & BluePrint ®)
Last week I was able first hand to see presentations in Texas on New breast cancer research incorporating the Symphony® suite of genomic tests (MammaPrint®, BluePrint® and TargetPrint®) in 10 scientific posters at the 2013 San Antonio Breast Cancer Symposium (SABCS).
“These ten studies further demonstrate Agendia’s continued commitment to providing the oncology community and their breast cancer patients with the most comprehensive and validated picture of tumor biology available in the market,” said Neil Barth, M.D., Agendia’s Chief Medical Officer.
Symphony is the only widely available test suite providing molecular subtyping -- a recent advancement in breast cancer prognosis and treatment that is highlighted in several SABCS posters. The second-generation MammaPrint test provides definitive High Risk or Low Risk information about breast cancer recurrence, with no “intermediate” results.
This new research has enhanced the way that I now make management recommendations to my new patients with breast cancer.
Monday, September 9, 2013
Too Busy for Breast Cancer Screening
One in two women are increasing their risk of breast cancer by skipping regular mammograms simply because they are too busy, according to alarming new research. Breast Screen NSW recently surveyed 1000 women aged 50-74 and found half missed their regular appointment, with most citing a "lack of time" as the reason despite 95 per cent agreeing the free screening could save their life. "Twelve women get diagnosed every day in NSW and 17 a week die of breast cancer, and many of these deaths don't need to happen because screening can pick up a cancer as small as a grain of rice before it's even able to be felt," Cancer Institute of NSW deputy CEO Professor Sanchia Aranda said.
I consider breast cancer screening time well spent, particularly if it saves your life!
I consider breast cancer screening time well spent, particularly if it saves your life!
Dr Guy Hingston.
Subscribe to:
Posts (Atom)